atorvastatin has been researched along with Muscle Weakness in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (10.00) | 29.6817 |
2010's | 16 (80.00) | 24.3611 |
2020's | 2 (10.00) | 2.80 |
Authors | Studies |
---|---|
Guidry, TJ; Jacobs, D; Sullivan, J; Wassell, K | 1 |
Duarte-Garcia, A; Harmon, DM; Michet, CJ | 1 |
Lazris, A; Roth, AR | 1 |
Ali, I; Ghaffar, MT; Radhakrishna, A; Whelan, B | 1 |
Butts, M; Spiro, J | 1 |
Christopher-Stine, L; Isackson, PJ; Kitzmiller, JP; Luzum, JA; Ma, C; Nguyen, LM; Ochs-Balcom, HM; Peltier, W; Tarnopolsky, M; Vladutiu, GD; Weisman, M; Wortmann, RL | 1 |
Ernste, F; Pitlick, M | 1 |
Arvikar, SL; Clement, NF; Freeman, MW; Goldstein, RH; Guidon, AC; Singh, AK | 1 |
Laaksonen, R | 1 |
Amato, AA; Puig, A; Scripko, PD | 1 |
Cunnane, G; Durcan, L; Gleeson, N; McKiernan, S | 1 |
Krossnes, BK; Ljøstad, U; Mygland, Å | 1 |
Constantin-Teodosiu, D; Greenhaff, PL; Mallinson, JE; Marimuthu, K; Murton, A; Rennie, MJ; Selby, A; Smith, K | 1 |
Bossuyt, X; Dobbels, L; Mahler, M; Van Damme, P | 1 |
Bründler, J; Oestmann, A; Repond, F | 1 |
Clarkson, PM; Grimaldi, AS; Haller, RG; Hoffman, EP; Levine, BD; Parker, BA; Pescatello, LS; Thompson, PD; White, CM | 1 |
Bruckert, E; Dallongeville, J; Rosenbaum, D; Sabouret, P | 1 |
Desplaces, N; Gabignon, C; Le Guyader, N; Lidove, O; Zeller, V; Ziza, JM | 1 |
Mongini, T; Musumeci, O; Olivero, N; Palmucci, L; Rodolico, C; Vercelli, L | 1 |
Fabian, V; Knezevic, W; Mastaglia, FL; Needham, M; Panegyres, P; Zilko, P | 1 |
1 review(s) available for atorvastatin and Muscle Weakness
1 trial(s) available for atorvastatin and Muscle Weakness
Article | Year |
---|---|
A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design.
Topics: Atorvastatin; Cholesterol, LDL; Coronary Artery Disease; Creatine Kinase; Decision Trees; Double-Blind Method; Exercise Test; Female; Health Status Indicators; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Isometric Contraction; Male; Motor Activity; Muscle Strength; Muscle Strength Dynamometer; Muscle Weakness; Muscle, Skeletal; Physical Endurance; Pyrroles; Research Design; Surveys and Questionnaires | 2010 |
18 other study(ies) available for atorvastatin and Muscle Weakness
Article | Year |
---|---|
Safety Outcomes of Atorvastatin 80 mg Versus Atorvastatin 40 mg in a Veteran Population.
Topics: Aged; Atorvastatin; Dose-Response Relationship, Drug; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Lipids; Male; Middle Aged; Muscle Weakness; Myalgia; Retrospective Studies; Veterans | 2020 |
76-Year-Old Woman With Generalized Weakness.
Topics: Aged; Atorvastatin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscle Weakness; Muscular Diseases | 2019 |
Overuse of Statins in Older Adults.
Topics: Accidental Falls; Aged, 80 and over; Atorvastatin; Cardiovascular Diseases; Fractures, Bone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscle Weakness; Patient Participation; Prescription Drug Overuse; Risk Factors | 2019 |
Statin-induced necrotising autoimmune myopathy: a rare complication of statin therapy.
Topics: Atorvastatin; Autoimmune Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscle Weakness; Muscular Diseases | 2021 |
Atorvastatin-Induced Dermatomyositis: Resolution With Change in Statin?
Topics: Antibodies, Antinuclear; Atorvastatin; Autoantibodies; Autoimmunity; Biopsy; Coronary Artery Disease; Dermatomyositis; Diagnosis, Differential; Drug Substitution; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Muscle Weakness; Pravastatin; Serologic Tests; Skin; Treatment Outcome | 2018 |
Clinical features related to statin-associated muscle symptoms.
Topics: Aged; Atorvastatin; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Logistic Models; Lovastatin; Male; Medical History Taking; Middle Aged; Muscle Weakness; Muscular Diseases; Myalgia; Obesity; Odds Ratio; Pravastatin; Retrospective Studies; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Smoking; White People | 2019 |
Anti-HMGCR myopathy presenting with acute systolic heart failure.
Topics: Aged; Anti-Inflammatory Agents; Anticholesteremic Agents; Atorvastatin; Creatine Kinase; Female; Heart Failure, Systolic; Humans; Hydroxymethylglutaryl CoA Reductases; Methylprednisolone; Muscle Weakness; Muscular Diseases; Treatment Outcome | 2019 |
Case 22-2019: A 65-Year-Old Woman with Weakness, Dark Urine, and Dysphagia.
Topics: Aged; Atorvastatin; Autoimmune Diseases; Carotid Artery, Internal; Cerebral Infarction; Deglutition Disorders; Diagnosis, Differential; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Angiography; Muscle Weakness; Muscle, Skeletal; Myoglobinuria; Myositis; Rhabdomyolysis; Tomography, X-Ray Computed | 2019 |
STOMPing forward: statins, muscle complaints and CK.
Topics: Atherosclerosis; Atorvastatin; Creatine Kinase; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscle Weakness; Muscle, Skeletal; Muscles; Muscular Diseases; Myalgia; Pyrroles; Randomized Controlled Trials as Topic | 2013 |
Mystery case: a 63-year-old man with progressive proximal pain and weakness.
Topics: Atorvastatin; Blood Sedimentation; C-Reactive Protein; Creatine Kinase; Diabetes Mellitus, Type 2; Disease Progression; Electromyography; Fatigue; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscle Weakness; Neuromuscular Junction Diseases; Pain; Pyrroles; Shoulder Pain; Tomography, X-Ray Computed | 2014 |
A benign tumor as the apparent trigger for myopathy.
Topics: Aged; Atorvastatin; Female; Gynecologic Surgical Procedures; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Leg; Leiomyoma; Muscle Weakness; Muscle, Skeletal; Muscular Diseases; Neoplasms; Pyrroles; Treatment Outcome; Uterine Neoplasms | 2014 |
Persisting weakness after withdrawal of a statin.
Topics: Aged, 80 and over; Atorvastatin; Autoimmune Diseases; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscle Weakness; Myositis; Necrosis; Pyrroles | 2014 |
Statin myalgia is not associated with reduced muscle strength, mass or protein turnover in older male volunteers, but is allied with a slowing of time to peak power output, insulin resistance and differential muscle mRNA expression.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Case-Control Studies; Humans; Insulin Resistance; Male; Muscle Contraction; Muscle Proteins; Muscle Strength; Muscle Weakness; Reaction Time; RNA, Messenger; Simvastatin | 2015 |
A 62-Year-Old Woman with Muscle Weakness.
Topics: Anti-Inflammatory Agents; Anticholesteremic Agents; Atorvastatin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Methylprednisolone; Middle Aged; Muscle Weakness; Muscles | 2015 |
Discontinuation of statin therapy due to muscular side effects: a survey in real life.
Topics: Adult; Aged; Atorvastatin; Dose-Response Relationship, Drug; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Motor Activity; Muscle Cramp; Muscle Weakness; Muscle, Skeletal; Musculoskeletal Diseases; Pain; Pyrimidines; Pyrroles; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Surveys and Questionnaires; Treatment Outcome | 2013 |
[Rhabdomyolysis following the coprescription of atorvastatin and fusidic acid].
Topics: Aged; Anti-Bacterial Agents; Atorvastatin; Creatine Kinase; Fusidic Acid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscle Weakness; Prosthesis-Related Infections; Pyrroles; Rhabdomyolysis; Staphylococcal Infections | 2013 |
Chinese red rice depletes muscle coenzyme Q10 and maintains muscle damage after discontinuation of statin treatment.
Topics: Aged; Ascomycota; Atorvastatin; Biological Products; Coenzymes; Creatine Kinase; Dietary Supplements; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Muscle Weakness; Muscle, Skeletal; Pyrroles; Ubiquinone | 2006 |
Progressive myopathy with up-regulation of MHC-I associated with statin therapy.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Atorvastatin; Creatine Kinase; Female; Folic Acid Antagonists; Genes, MHC Class I; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Male; Methotrexate; Middle Aged; Mitochondria, Muscle; Muscle Weakness; Muscular Diseases; Prednisolone; Pyrroles; Sarcolemma; Simvastatin; Up-Regulation | 2007 |